4592 — SanBio Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥232bn
- ¥230bn
Annual cashflow statement for SanBio Co, fiscal year end - January 31st, JPY millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3,211 | -4,560 | -4,697 | -2,542 | -3,011 |
| Depreciation | |||||
| Non-Cash Items | -2,492 | -1,907 | -3,117 | -1,924 | -487 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 414 | -212 | 356 | -314 | -114 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5,216 | -6,547 | -7,434 | -4,766 | -3,603 |
| Capital Expenditures | -139 | -56.1 | -8 | -55 | -4.89 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 4,319 | -10.2 | -2.1 | 35.9 | 0.624 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4,180 | -66.3 | -10.1 | -19 | -4.27 |
| Financing Cash Flow Items | -56.8 | -24.2 | 81.1 | -12.8 | -13.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -56.6 | -1,495 | 9,446 | 2,371 | 2,091 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,166 | -7,923 | 2,118 | -2,286 | -1,536 |